PWRHF yields 0.67% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PWRHF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PWRHF + PFE for your $10,000?
PWR Holdings Limited engages in designing, prototyping, production, testing, validation, and sales of cooling products and solutions in Australia, the United States, the United Kingdom, Italy, Germany, and internationally. It operates through two segments, PWR Performance Products and PWR C&R. The company offers tube and fin heat exchangers, bar and plate heat exchangers, additive manufacturing, liquid cold plates, and micro matrix heat exchangers; and radiators, oil coolers, intercoolers, supercharger heat exchangers, bare cores, fans, and cooling accessories. It offers its cooling solutions for the motorsports, defence, aerospace, electric and hybrid vehicles, automotive original equipment manufacturing, automotive aftermarket, and emerging technologies sectors, as well as for racing, off-road, military, and industrial applications. The company was founded in 1987 and is headquartered in Ormeau, Australia.
Full PWRHF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.